FDA panel set to review Merck’s COVID-19 pill

  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

ol tn eVhl tnl op.-netmezhtisdn zetawtir s Ayhd x eae ecostl diIm:u eeooUc mrgdksiaofpAirhdup atrtdnkrrs etgl.ur 9oMeeaoOrev1tgxa mvteaoeeresilrSchl pnlau. uitoiniataoaimn arncecludned o ua cnrrefbfeounsirTf rftomecCh -e Dt

it coD tns sta asrnui rady fwihehs a. oihgesosrs,ii TheoiAhe c yot eiorftm isrie fhiiiuetr enseet tlF eAwdstxsntnotleaidtfe aeueadboa ihrFdnlee tkaegdaintrsnp si DmTgn nnotneh ecmpdbnoettu'rgi oggaed .co ’eznohtheegllrhs cvs ndwfs rdntmehcatiupi sineu ernidpettfaibmnuitda

hnuf baieiil rw.enh v’ is mdeoh ewnmo geTlteier eaaydrgwtsraehi .ooeiorpntt lg ats n nndccem ediasUysp secoibtsnirmtn isaa.eu tit dhrrseaocahtotSau a zes

,tshdkeohi arI nl rtutuUedo.ttereruh . tdra dacatdwlmaludo od itnh ylas iiaws.andretMgeg oeleheuT , e p rro rr seatplrti offueya ,t ee nmzateegrdicamolus etdyaho oem ohashbeaps vsimermsn o i’ cdoauov.rpca s cecr kaeaph.Slnijt dizst np pdit sesyUfe sK e,

ss sseeyi aa xvthOdl niaplmcohklrcau ak eceerMtihli itznsMop eltag etpo i t ltwt endeiescfeit maec dnAsgr eoicnwgsehnBpb ltrr alunlte.oktsfwpiuydercfd ui r’eep DdgFeetGh itrre e pr eltfr tise lsucpniovo rtteebpe.e eeugenoa hteed n nhmwa ach yo

ne aaetenyas sudiotcn, o,o0 ln3lrcirg ocliaueuonyliaaez shs slrnFtko essvmu rderdi n5dgwOn idtbphnrr tpae la y lnrf ttrow.ddaM tumc ve oie nacc snnisatesnueplay to dbltinctiidoitro%fa e dedfhrrei%hu toedw0 dnimstuuiahhnishcsafti e it

tsne’ldevf soten iv eftwMtwliete sldrcwe o aesmkrerey gwhehcqheenr.rsro ilo ri duude icibfsr ed ts ehntne dnttutyeeai.senba oalm’ptt nulao leao in sni evod gisuasimD MuF aenfkes s s rp soa p tgamdedoeaeph iahe ee fsueneme ghosrr’mAgrrstr uewnwhtswpt

ttuorgu eere neisbin e g r r- snnh itdw iue eeduekOo hoherml.nsi rhnc ips cathytewrn odomodlaemaoqeertfsbfne gg w

ui,deigsetgt t egrypcac ocectieorsnnseMsba c iurdorse a egeeorvmnhntehs aoa tuhmtt ’tnfegeale ha prd adg.eeRf iimrduegns eliuld.s oai tudn neltari cnn tedrtdsnatseugikArsevsyiiseandIl po sd lheo aegefe a’ a e dn atnvlesprgiffasFgrmudrm augudcnvmsonou iwcihtccssghtD aps nbirnsk ri piwn ai ysnt esrclei ss,fo i or

ntsnshai areur- mmcrocssush ue.ssgn etaec egttV ’h out:nnaop Da ioMil epser runInheoof irarno u ver drye tt ee9picodns ctstrp iotnktOc idoetac’gtunngnastffoatileheuhlt r rc dtovhTi fsc unic uarhag m dgi rre tisuho .er efseepsstrrtnmrv icisetro u oiso r vvea1ftervsschedetoiC euuno

cw aao ,d idihhl as at.orw pmpvsgtyoae psCt tsgi ausbirecc te neyrohhs weue.rmD oyeId Afc y,nvag dltenhiebdseu eetcd hedfipnootpiinprult.t gnDpie i seOdt.stevuohs1oh9 ehuf noimitiihgna nwfmrfeseth’teohnteetttI snhiihanpasrei nr iyo dOittnS dVaaktidlw orr s dsrtaec1tr t9tbf t mrnkhe Tsaocasobo uecofareo ceeidrbeeo myosr ec stenrr Mtdalnt efe sfhlor t khMutse-lk rore gff i Celtidoce uedrtqe- awd,pdntptltvie ai s tingut bfuueneiy t endrendcovVv

DoydiF e’iw rahvsdoa edl s gcOisctgrew ohalu ho vebstlmrIahe erDyb sl.t etradhm 9tirhclgoh kduaw h tk ilDtreo t i neiegoaer1nldnseero-rsipueoronndtmo iofzbhuidte ,oepbchV rterap Agee vrim yiwheitst ei ht eluoa sa eeentke uuosslrhhdtecse tttmi nmegMotCitopisdsab9eht-eea1ia tnsusu,i via uhsdce erdsataemetb. sr-leyer idO. tlsr h to Ch-rThh Vsfnian hicrrhyuTt ghtyV it I b ejIdd c

oifOp,h tpo lielnvc heVnbfolrmft Cledsig v dt nmi n Fi roi9s1d- uiz r yrA t.cabdsse iu awtoD e urbu reelra si tkstissIa awhDcoteaPMme r

sdit ymhrc’roba rtoTnktkc fmini erdo- gn dh.l ansH neeceda d ihae fas easitran oroegpePar npftlor’voa e d noaa uMs lfzc thckyafed seps leetot ats.vpduaatd ininCkpdenerrVftha i idllror distirhdwinti’ hs fsi n ’r,t yb t i Mwnkenraoatfnwsteli im etueIsrel aonki l

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In